John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$226M |
| 2 |
JPMorgan Chase
JPM
|
+$212M |
| 3 |
TSMC
TSM
|
+$204M |
| 4 |
Occidental Petroleum
OXY
|
+$194M |
| 5 |
Apple
AAPL
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$271M |
| 2 |
Microsoft
MSFT
|
+$267M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$255M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$226M |
| 5 |
Coca-Cola
KO
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.48% |
| 2 | Healthcare | 15.21% |
| 3 | Industrials | 10.23% |
| 4 | Consumer Discretionary | 10.15% |
| 5 | Financials | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
State Street SPDR S&P Biotech ETF
XBI
$11.2B
| $33.4M | 0.1% |
371,500
+246,142
| +196% | +$22.7M |
|
252
Healthcare Realty
HR
$6.65B
| $33.3M | 0.1% |
1,064,102
+1,016,449
| +2,133% | +$32M |
|
253
Wendy's
WEN
$1.72B
| $33.1M | 0.1% |
1,508,245
-341,677
| -18% | -$7.7M |
|
254
AES
AES
$10.5B
| $32.9M | 0.1% |
1,280,246
+436,993
| +52% | +$9.88M |
|
255
Thomson Reuters
TRI
$45.7B
| $32.8M | 0.1% |
286,221
+240,780
| +530% | +$26.9M |
|
|
CUK
256
DELISTED
Carnival PLC
CUK
| $32.6M | 0.1% |
1,783,206
+275,629
| +18% | +$5.15M |
|
|
NVTA
257
DELISTED
Invitae Corporation
NVTA
| $32.5M | 0.1% |
4,076,162
+2,634,641
| +183% | +$26.5M |
|
258
Li Auto
LI
$12.8B
| $32.5M | 0.1% |
1,257,327
+682,256
| +119% | +$18.8M |
|
259
UiPath
PATH
$8.49B
| $32.4M | 0.1% |
1,498,528
+1,361,647
| +995% | +$45.9M |
|
260
Warner Bros
WBD
$71.6B
| $32.2M | 0.1% |
1,292,021
-666,454
| -34% | -$18.3M |
|
261
Star Bulk Carriers
SBLK
$3.41B
| $32.2M | 0.09% |
1,083,004
+293,677
| +37% | +$7.68M |
|
262
Rogers Communications
RCI
$19.6B
| $32.1M | 0.09% |
566,482
+184,000
| +48% | +$9.51M |
|
263
WEX
WEX
$6.81B
| $32M | 0.09% |
179,331
+176,526
| +6,293% | +$28.8M |
|
264
Tractor Supply
TSCO
$18.2B
| $32M | 0.09% |
685,025
-1,442,190
| -68% | -$63.8M |
|
265
Flowserve
FLS
$10.1B
| $31.9M | 0.09% |
888,787
+282,104
| +46% | +$9.22M |
|
266
WEC Energy
WEC
$34.5B
| $31.8M | 0.09% |
318,399
+173,838
| +120% | +$16.4M |
|
|
SPR
267
DELISTED
Spirit AeroSystems
SPR
| $31.7M | 0.09% |
649,209
+461,626
| +246% | +$21.6M |
|
268
PPG Industries
PPG
$25.3B
| $31.5M | 0.09% |
+240,325
| New | +$34.9M |
|
269
Edwards Lifesciences
EW
$51.8B
| $31.1M | 0.09% |
264,290
-847,527
| -76% | -$95.1M |
|
270
IDEX
IEX
$17.3B
| $31.1M | 0.09% |
162,237
+138,518
| +584% | +$28.1M |
|
271
MP Materials
MP
$10.7B
| $30.7M | 0.09% |
535,257
+108,216
| +25% | +$4.76M |
|
272
Franco-Nevada
FNV
$51.3B
| $30.5M | 0.09% |
191,240
+33,887
| +22% | +$4.88M |
|
273
Cardinal Health
CAH
$53.4B
| $30.4M | 0.09% |
536,216
-1,779,067
| -77% | -$95.3M |
|
274
Comstock Resources
CRK
$4.18B
| $30.4M | 0.09% |
2,328,897
+790,834
| +51% | +$7.04M |
|
|
SAVE
275
DELISTED
Spirit Airlines, Inc.
SAVE
| $30.4M | 0.09% |
1,388,771
+1,065,425
| +329% | +$24.4M |
|
Similar funds
John Overdeck's Q1 2022 Portfolio in Review
As of Q1 2022, John Overdeck held 4,846 positions worth $33.9B, down 28% from $46.8B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
John Overdeck withdrew a net $11.3B in Q1 2022, closing 2,304 positions and reducing 976 holdings. Its most notable exit was Pfizer, an estimated $271M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, John Overdeck opened a new position in Cisco worth $223M.
- John Overdeck's largest Q1 2022 buy was Cisco: 4,001,362 shares worth $223M.
- John Overdeck added most to JPMorgan Chase in Q1 2022, an estimated $212M increase.
- John Overdeck's biggest Q1 2022 reduction was Coca-Cola, cutting an estimated $225M.
- John Overdeck fully exited Pfizer in Q1 2022, selling an estimated $271M.
- John Overdeck's ten largest holdings make up 7.2% of its $33.9B portfolio in Q1 2022.
- John Overdeck opened 656 new positions and closed 2,304 in Q1 2022.
- John Overdeck's portfolio value fell 28% quarter-over-quarter to $33.9B.
Based on Two Sigma Investments's 13F filing for Q1 2022, filed 16 May 2022.